NASDAQ : MOBI
-$0.02 (-0.17%)
| Source | Headline |
|---|---|
|
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report second quarter 2026 financial results on Tuesday, August 11, 2026. Mobia Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. globenewswire.com - 2026-07-21 16:05:00 |
|
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Reza Zadno, Ph.D., to the Board as an independent director, effective July 14, 2026. Dr. Zadno will also serve as a member of the Compensation Committee. globenewswire.com - 2026-07-15 16:05:00 |
|
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two years Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two years globenewswire.com - 2026-07-14 16:18:00 |
|
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to maintain CPT® Code 64568, the procedure code used for the Vivistim® procedure, under the New Technology Ambulatory Payment Classification (APC) 1580 for calendar year (CY) 2027, with an associated hospital outpatient payment rate of approximately $45,000, unchanged from the CY 2026 rate. CMS is expected to publish the final Hospital Outpatient Prospective Payment System (OPPS) rule in November of this year, with any changes taking effect January 1, 2027. globenewswire.com - 2026-07-02 16:35:00 |
|
Primary Markets Group May 2026 U.S. IPO Monthly
The U.S. IPO market maintained its strong momentum in May with 12 offerings raising $13.1 billion in total proceeds, which was well above April's $8.2 billion in total proceeds but one short on deal count. The largest deal of the month was technology firm Cerebras Systems' $6.4 billion raise, making it the largest IPO since Medline Inc.'s $7.2 billion raise in December 2025 and the biggest tech IPO since Uber Technologies' $8.1 billion in May 2019. The healthcare sector saw three new issuers, led by GMR Solutions' $478.7 million offering. seekingalpha.com - 2026-06-07 10:05:00 |
|
Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy' rating and a $16 price target by Bank of America, which cited the company's growth potential in stroke recovery treatment and a large addressable market for its Vivistim system. Mobia's Vivistim therapy combines rehabilitation exercises with a vagus nerve stimulation (VNS) device designed to help chronic stroke survivors improve upper-limb function. proactiveinvestors.com - 2026-06-02 15:31:55 |
|
Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy’ rating and a $16 price target by Bank of America, which cited the company's growth potential in... proactiveinvestors.com - 2026-06-02 11:28:00 |
|
Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip
Healthcare IPO demand is coming back, but investors are not giving every new listing an easy first-day win. Odyssey Therapeutics (ODTX) and Mobia Medical (MOBI) gurufocus.com - 2026-05-11 07:31:00 |
|
Mobia Medical: A Tough Debut For This Stroke Medical Business
Mobia Medical went public, with shares dropping over 20% on debut, reflecting investor caution over mounting losses despite strong sales growth. Mobia Medical's Vivistim Paired VNS system targets a large stroke recovery market, with revenues doubling to $32M in 2025 but operating losses also nearly doubling. Despite robust top line momentum and a ~$200M net cash position, persistent lack of operating leverage and high per-patient costs raise concerns. seekingalpha.com - 2026-05-10 02:20:22 |